S026 Late-breaking Research: Session 1
DESCRIPTION
Investigators can submit abstracts describing their most recent unpublished results in all aspects of dermatological research. After a competitive review, the top-scoring studies will be invited to discuss their findings in a brief oral presentation. Emphasis will be placed on practice-changing clinical trials, large population-based studies, innovative new transformative technologies, translationally relevant biomarker studies, and basic science research that sheds light on mechanisms of disease, therapy, or adverse events. All topics related to disorders of the skin, hair and nails will be considered.
LEARNING OBJECTIVES
Describe ground-breaking scientific developments in dermatologic research.
Evaluate and apply information from recent investigations to clinical practice.
SCHEDULE
9:00 AM
Efficacy and safety of the oral BrutonÂ’s tyrosine kinase inhibitor, remibrutinib, in patients with moderate to severe hidradenitis suppurativa in a randomized, phase 2, double-blind, placebo-controll
Alexandra Boer Kimball, MD, MPH, FAAD
9:10 AM
High Induction Dosing of Risankizumab in Patients with Moderate-to-Severe Plaque Psoriasis: 52-Week Results from the Phase 2 KNOCKOUT Study
Andrew Blauvelt, MD, FAAD
9:20 AM
Efficacy and Safety of Apremilast for the Treatment of Japanese Patients With Palmoplantar Pustulosis (PPP): 16-Week Results From a Phase 3, Randomized, Placebo-Controlled Study
Tadashi Terui
9:30 AM
A Phase 2 Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of Lutikizumab in Adult Patients with Moderate to Severe Hidradenitis Suppurativa Who Have
Falk Bechara
9:40 AM
A Phase 2B Clinical Trial: Assessing the Efficacy of Injectable Polidocanol for Excess Submental Fat Reduction
Kavita Darji, MD
9:50 AM
The Light Treatment Effectiveness (LITE) Study: A pragmatic trial of home versus office-based narrow band ultraviolet B phototherapy for the treatment of psoriasis in the United States
Joel M. Gelfand, MD, MSCE, FAAD
10:00 AM
Efficacy and safety of coacillium in children and adolescents with moderate to severe alopecia areata: a randomised, double-blind, placebo-controlled, international, phase 2-3 trial
Bianca Maria Piraccini, MD, IFAAD
10:10 AM
Long-Term Safety and Efficacy of Beremagene Geperpavec (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa
Amy S. Paller, MD, FAAD
10:20 AM
Efficacy and Safety of ESK-001, a highly selective oral TYK2 inhibitor, in a Phase 2 study in adults with moderate-to-severe plaque psoriasis (STRIDE)
Kim A. Papp, MD, FAAD
10:30 AM
Brepocitinib induces clinical improvement in patients with cicatricial alopecia and attenuates scalp inflammatory biomarkers
Marguerite Meariman, MD, MPH
10:40 AM
Response to ritlecitinib with or without narrow band ultraviolet B (nbUVB) add-on therapy in patients with active non-segmental vitiligo (NSV)
Emma Guttman, MD, PhD, FAAD
10:50 AM
Efficacy of ritlecitinib up to Month 24 in patients with alopecia totalis (AT) and alopecia universalis (AU) from the ALLEGRO phase 2b/3 and long-term phase 3 clinical studies
Melissa Piliang, MD, FAAD
11:00 AM
A Phase 2b, Long-term Extension, Dose-ranging Study of Oral JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis: FRONTIER-2
Laura K. Ferris, MD, PhD, FAAD
11:10 AM
Long-term safety and efficacy of delgocitinib cream for up to 36 weeks in adults with Chronic Hand Eczema: results of the Phase 3 open-label extension DELTA-3 trial
Melinda Gooderham, MD, FAAD
11:20 AM
Bimekizumab efficacy from treatment initiation through 4 years in patients with plaque psoriasis: A comprehensive, long-term, pooled analysis from BE BRIGHT
Mark Lebwohl, MD, FAAD
11:30 AM
Efficacy and Safety After 52 Weeks of Once-Daily Upadacitinib in Adults With Extensive Non-Segmental Vitiligo (NSV): Final Results From a Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Contro
Thierry Passeron, MD, PhD
11:40 AM
Inhibition of pyruvate oxidation activates human hair follicle stem cells ex vivo
Christina Weng, MD, FAAD
11:50 AM
Guselkumab showed good efficacy in treating generalized pustular psoriasis, with a low relapse rate and reduction in CD8+ tissue-resident memory T cells
Jiajing Lu
DIRECTOR
Hensin Tsao, MD, PhD, FAAD
SPEAKERS
Murad Alam, MD, FAAD
April W. Armstrong, MD, MPH, FAAD
Falk Bechara
Andrew Blauvelt, MD, FAAD
Kavita Darji, MD
Robert Paul Dellavalle, MD, PhD, FAAD
Laura K. Ferris, MD, PhD, FAAD
Joel M. Gelfand, MD, MSCE, FAAD
Melinda Gooderham, MD, FAAD
Kenneth B. Gordon, MD, FAAD
Emma Guttman, MD, PhD, FAAD
Sewon Kang, MD, FAAD
Alexandra Boer Kimball, MD, MPH, FAAD
Mark Lebwohl, MD, FAAD
Jiajing Lu
Marguerite Meariman, MD, MPH
Paul Nghiem, MD, PhD, FAAD
Amy S. Paller, MD, FAAD
Kim A. Papp, MD, FAAD
Thierry Passeron, MD, PhD
Melissa Piliang, MD, FAAD
Bianca Maria Piraccini, MD, IFAAD
Tadashi Terui
Sandy Sharon Tsao, MD, FAAD
Christina Weng, MD, FAAD
HANDOUTS
DISCLOSURES
Murad Alam, MD, FAAD
No financial relationships exist with ineligible companies.
April W. Armstrong, MD, MPH, FAAD
AbbVie – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Amgen – Advisory Board(Honoraria); Arcutis Biotherapeutics – Consultant(Honoraria); Boehringer Ingelheim – Data Safety Monitoring Board(Honoraria); Bristol-Myers Squibb – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Dermavant Sciences, Inc. – Consultant(Honoraria); Dermsquared – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria); Galderma USA – Advisory Board(Honoraria); Incyte – Consultant (1099 relationship)(Honoraria); Janssen Biotech – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc – Consultant(Honoraria); Novartis – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Ortho Dermatologics – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Regeneron – Advisory Board(Honoraria); Sanofi Genzyme – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria);
Falk Bechara
AbbVie – Advisory Board(Fees); Acelyrin – Other(Fees); Boehringer Ingelheim – Other(Fees); Celltrion – Advisory Board(Fees); Dr. August Wolff GmbH& Co. – Advisory Board(Fees); Incyte – Other(Fees); Janssen-Cilag – Speaker(Fees); Mölnlycke – Other(Fees); MoonLake Immunotherapeutics – Advisory Board(Fees); Novartis – Speaker(Fees); UCB Pharma – Speaker(Fees);
Andrew Blauvelt, MD, FAAD
AbbVie – Consultant(Honoraria); Almirall – Consultant(Honoraria); Alumis – Consultant (1099 relationship)(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria); AnaptysBio – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis, Inc. – Consultant (1099 relationship)(Honoraria); Eli Lilly and Company – Consultant(Honoraria), Speaker(Honoraria); Incyte Corporation – Consultant(Honoraria); Janssen-Ortho Inc. – Consultant(Honoraria); Leo Pharma Inc – Consultant(Honoraria); Novartis Pharmaceuticals Corp. – Consultant(Honoraria); Oruka Therapeutics – Consultant (1099 relationship)(Honoraria), Stockholder Public Company(Stock); Pfizer Inc. – Consultant(Honoraria); Regeneron – Consultant(Honoraria); Sanofi – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria), Speaker(Honoraria);
Kavita Darji, MD
No financial relationships exist with ineligible companies.
Robert Paul Dellavalle, MD, PhD, FAAD
American Board of Dermatology – Other(No Compensation Received); JMIR Dermatology – Other(Salary); UCB – Consultant (1099 relationship)(Honoraria); WoltersKluwer Health – Other(Patent royalties or other compensation for Intellectual Property Rights);
Laura K. Ferris, MD, PhD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Other Financial Benefit); Almirall – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Other Financial Benefit); Arcutis, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Other Financial Benefit), Speaker(Honoraria); Bristol-Myers Squibb – Consultant(Honoraria); Cara Therapeutics – Consultant(Honoraria); Castle Biosciences, Inc – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Janssen Research & Development, LLC – Investigator(Other Financial Benefit); Novartis – Investigator(Other Financial Benefit); Pfizer Inc. – Data Safety Monitoring Board(Honoraria); Regeneron – Consultant(Honoraria), Investigator(Other Financial Benefit); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Verrica Pharmaceuticals Inc – Investigator(Grants/Research Funding);
Joel M. Gelfand, MD, MSCE, FAAD
AbbVie – Consultant(Fees); Alumis – Consultant (1099 relationship)(Fees); Alyson Oliver Partner & Attorney – Consultant (1099 relationship)(Fees); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); Arnold & Porter – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Bristol Myers Squibb – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); FIDE – Consultant(Fees); Healio – Other(Fees); Inmagene Biopharmaceuticals – Data Safety Monitoring Board(Fees); International Psoriasis Council – Board of Directors(No Compensation Received); Johnson & Johnson Innovative Medicine – Consultant (1099 relationship)(Fees); Leo Pharma Inc – Consultant(Fees); Maui Derm – Speaker/Faculty Education(Fees); Medical Dermatology Society – Board of Directors(No Compensation Received); Moonlake – Data Safety Monitoring Board(Fees); National Psoriasis Foundation – Investigator(Grants/Research Funding); Neuroderm LTD – Other(Fees); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant (1099 relationship)(Fees);
Melinda Gooderham, MD, FAAD
AbbVie – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Acelyrin – Investigator(Grants/Research Funding); Amgen – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); AnaptysBio – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Aristea Therapeutics – Investigator(Grants/Research Funding); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); Bausch Health – Consultant(Honoraria), Investigator(Grants/Research Funding); Boehringer Ingelheim – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Bristol-Myers Squibb – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Cara Therapeutics – Investigator(Grants/Research Funding); Dermavant Sciences – Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Galderma Laboratories, LP – Investigator(Grants/Research Funding), Speaker(Honoraria); Incyte – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Inmagene Biopharmaceuticals – Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc. – Speaker(Honoraria); Meiji Seika Pharma Co., Ltd – Investigator(Grants/Research Funding); Moonlake – Investigator(Grants/Research Funding); Nimbus Therapeutics – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Regeneron – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Reistone Biopharma – Investigator(Grants/Research Funding); Sanofi Genzyme – Consultant(Honoraria), Speaker(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Tarsus – Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria), Data Safety Monitoring Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Ventyx Biosciences – Investigator(Grants/Research Funding); VYNE Therapeutics – Investigator(Grants/Research Funding);
Kenneth B. Gordon, MD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Amgen – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria); Othro Dermatologics – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Protagonist Therapeutics – Consultant (1099 relationship)(Honoraria); Sanofi Genzyme – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant(Honoraria);
Emma Guttman, MD, PhD, FAAD
AbbVie – Consultant(Fees), Consultant(Honoraria); Almirall – Consultant(Fees); Amgen – Consultant(Fees), Investigator(Grants/Research Funding); AnaptysBio – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Apollo Therapeutics Ltd – Investigator(Grants/Research Funding); Artax Biopharma – Consultant (1099 relationship)(Fees); Astria Therapeutics – Consultant (1099 relationship)(Fees); Bambusa Therapeutics Inc – Consultant (1099 relationship)(Fees); Biolojic Design – Consultant (1099 relationship)(Fees); Bionyra Pharma – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Consultant(Fees); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Celldex – Consultant (1099 relationship)(Fees); Cue Biopharma – Consultant (1099 relationship)(Fees); CytoReason – Consultant (1099 relationship)(Fees); DBV Technologies – Consultant (1099 relationship)(Fees); Dualitas Therapeutics – Consultant (1099 relationship)(Fees); Electra Therapeutics – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); EMD Serono – Consultant (1099 relationship)(Fees); Enveda Biosciences – Consultant (1099 relationship)(Fees); Evommune, Inc. – Consultant (1099 relationship)(Fees); Galderma Research & Development, LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Generate Biomedicines – Consultant (1099 relationship)(Fees); Gilead Sciences, Inc – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Infimmune – Consultant (1099 relationship)(Fees); Inmagene Biopharmaceuticals – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Janssen – Consultant (1099 relationship)(Fees); Jasper Therapeutics – Consultant (1099 relationship)(Fees); Kymera Therapeutics – Consultant (1099 relationship)(Fees); Kyowa Hakko Kirin Pharma, Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Leo Pharma Inc – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Matchpoint Therapeutics – Consultant (1099 relationship)(Fees); Merck – Consultant(Fees), Consultant(Honoraria); Navigator Medicines – Consultant (1099 relationship)(Fees); Nektar Therapeutics – Consultant (1099 relationship)(Fees); Opsidio – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Propeller Bio – Consultant (1099 relationship)(Fees); Proteologix US Inc – Consultant (1099 relationship)(Fees); RAPT Therapeutics – Consultant (1099 relationship)(Fees), Consultant (1099 relationship)(Honoraria), Consultant (1099 relationship)(Stock Options), Investigator(Grants/Research Funding); RayThera – Consultant (1099 relationship)(Fees); Regeneron – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Rubedo Life Sciences – Consultant (1099 relationship)(Fees); Sanofi – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); SATO Pharmaceutical Co., Ltd – Consultant(Fees); Sitryx – Consultant (1099 relationship)(Fees); Sun Pharma Advanced Research Company (SPARC) – Consultant (1099 relationship)(Fees); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Fees); Teva – Consultant (1099 relationship)(Fees); TRex Bio – Consultant (1099 relationship)(Fees); Triveni Bio – Consultant (1099 relationship)(Fees); UCB – Consultant(Fees), Investigator(Grants/Research Funding); Ventyx Biosciences – Consultant (1099 relationship)(Fees); VeraDermics Inc. – Consultant (1099 relationship)(Fees); VRG Therapeutics – Consultant (1099 relationship)(Fees); Xencor – Consultant (1099 relationship)(Fees);
Sewon Kang, MD, FAAD
Allergan, Inc – Advisory Board(Honoraria); CeraVe/Valeante – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria); Estee Lauder – Advisory Board(Honoraria); Galderma USA – Advisory Board(Honoraria); Incyte Corporation – Data Safety Monitoring Board(Fees); Rapalogix Health – Advisory Board(Stock Options); Walgreens Boots Alliance, Inc. – Investigator(Grants/Research Funding);
Alexandra Boer Kimball, MD, MPH, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Acelyrin – Investigator(Grants/Research Funding); Almirall – Board of Directors(Fees), Consultant(Honoraria); AnaptysBio – Investigator(Grants/Research Funding); Avalo Therapeutics Inc – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Beth Israel Deaconess Medical Center – Other(Patent royalties or other compensation for Intellectual Property Rights); BMS – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Fees); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Cellarity – Consultant (1099 relationship)(Fees); Citryll – Consultant (1099 relationship)(Fees); Curogen – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Consultant(Honoraria), Investigator(Grants/Research Funding); FIDE – Consultant(Fees); Incyte – Investigator(Grants/Research Funding); Incyte Corporation – Consultant (1099 relationship)(Fees); Innovaderm Research Inc. – Speaker(Honoraria); Insmed Incorporated – Investigator(Grants/Research Funding); Janssen Biotech – Consultant(Honoraria); Janssen Research & Development, LLC – Investigator(Grants/Research Funding); Merck – Consultant (1099 relationship)(Fees); Moonlake – Consultant(Fees), Investigator(Grants/Research Funding); Novartis – Consultant(Honoraria), Investigator(Grants/Research Funding); Nurix – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Prometheus Laboratories, Inc. – Investigator(Other Financial Benefit); Regeneron Pharmaceuticals Inc – Consultant (1099 relationship)(Fees); Sanofi – Consultant(Honoraria), Investigator(Fees); Sonoma Bio – Consultant(Fees); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Fees); Target RWE – Advisory Board(Fees); UCB – Consultant(Honoraria), Investigator(Grants/Research Funding); UCSD – Advisory Board(Honoraria); Union Therapeutics – Consultant (1099 relationship)(Fees); Ventyx Biosciences – Consultant(Fees), Consultant(Stock Options); Zura Bio – Consultant (1099 relationship)(Fees);
Mark Lebwohl, MD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Added Health – Consultant (1099 relationship)(Honoraria); Aikium – Consultant (1099 relationship)(Honoraria); Almirall – Consultant(Honoraria); AltruBio Inc. – Consultant(Honoraria); Alumis – Consultant (1099 relationship)(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); AstraZeneca – Consultant (1099 relationship)(Honoraria); Atomwise – Consultant(Honoraria); Avotres, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Bausch Health – Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol Myers Squibb – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Cara Therapeutics – Investigator(Grants/Research Funding); Castle Biosciences, Inc – Consultant(Honoraria); Celltrion – Consultant(Honoraria); Clexio Biosciences, Ltd – Investigator(Grants/Research Funding); CoreEvitas, LLC – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); Dermsquared – Consultant (1099 relationship)(Honoraria); Edesa Biotech – Consultant (1099 relationship)(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Evommune, Inc. – Consultant(Honoraria); Facilitation of International Dermatology Education – Consultant(Honoraria); Forte Biosciences – Consultant(Honoraria); Galderma – Consultant(Honoraria); Genentech, Inc. – Consultant(Honoraria); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Inozyme Pharma – Investigator(Grants/Research Funding); J&J Innovative Medicine – Consultant (1099 relationship)(Honoraria); Janssen Research & Development, LLC – Investigator(Grants/Research Funding); Leo Pharma A/S – Consultant(Honoraria); Mayne Pharma Group – Consultant (1099 relationship)(Honoraria); Meiji Seika Pharma Co., Ltd – Consultant(Honoraria); Mindera – Consultant(Honoraria); Mirum Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Honoraria); New York College of Podiatric Medicine – Speaker/Faculty Education(Honoraria); Oruka Therapeutics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Revolo Therapeutics – Consultant (1099 relationship)(Honoraria); Sanofi/Regeneron – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Seanergy Maritime Holdings Corp. – Consultant(Honoraria); Strata Skin Sciences – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); Teva Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Trevi Therapeutics – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding); Verrica Pharmaceuticals Inc – Consultant(Honoraria);
Jiajing Lu
No financial relationships exist with ineligible companies.
Marguerite Meariman, MD, MPH
AbbVie – Consultant (1099 relationship)(Fees);
Paul Nghiem, MD, PhD, FAAD
Almirall – Consultant(Honoraria); Bristol-Myers Squibb – Investigator(Grants/Research Funding); EMD Serono – Consultant(Fees); Merck & Co., Inc – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria);
Amy S. Paller, MD, FAAD
AbbVie – Data Safety Monitoring Board(Honoraria), Investigator(Grants/Research Funding); Abeona Therapeutics – Data Safety Monitoring Board(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); BioCryst Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); BioMendics, LLC – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria); Castle Creek Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Chiesi Farmaceutici – Consultant (1099 relationship)(Honoraria); Daiichi Sankyo – Data Safety Monitoring Board(Honoraria); Dermavant Sciences, Inc. – Investigator(Grants/Research Funding); Eli Lilly – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Galderma – Data Safety Monitoring Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Krystal Biotech, Inc – Consultant(Honoraria); L'Oréal France – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc – Consultant(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Honoraria); Pelthos Therapeutics – Consultant (1099 relationship)(Honoraria); Quoin Pharmaceuticals Ltd – Consultant (1099 relationship)(Honoraria); Regeneron – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi Genzyme – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding);
Kim A. Papp, MD, FAAD
AbbVie – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Acelyrin – Consultant(Honoraria), Investigator(Grants/Research Funding); Akros Pharma, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Alumis – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Amgen – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Arcutis, Inc. – Consultant(Grants/Research Funding), Investigator(Grants/Research Funding); Avillion – Consultant(Grants/Research Funding), Investigator(Grants/Research Funding); Bausch Health – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Celltrion – Consultant(Honoraria); CorEvitas – Investigator(Grants/Research Funding); Dermavant Sciences – Consultant(Grants/Research Funding), Investigator(Grants/Research Funding); DICE Therapeutics – Consultant(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Forbion – Consultant(Honoraria); Galderma Canada, Inc – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Hengrui – Consultant (1099 relationship)(Honoraria); Incyte Corporation – Consultant(Grants/Research Funding), Investigator(Grants/Research Funding), Speaker(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Fees), Speaker(Honoraria); Kymab – Investigator(Grants/Research Funding); Kyowa Hakko Kirin Pharma, Inc. – Consultant(Honoraria), Speaker(Honoraria); Leo Pharma Inc – Consultant(Grants/Research Funding), Investigator(Grants/Research Funding), Speaker(Honoraria); Navigator Medicines – Consultant (1099 relationship)(Honoraria); Nektar Therapeutics – Consultant (1099 relationship)(Honoraria); Nimbus Therapeutics – Consultant(Honoraria); Novartis – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Sanofi – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Tarsus – Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Zai Lab – Investigator(Grants/Research Funding);
Thierry Passeron, MD, PhD
AbbVie – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); Almirall – Advisory Board(Honoraria); Amgen – Consultant(Honoraria); Astellas Pharma US, Inc – Investigator(Grants/Research Funding); Beiersdorf, Inc. – Speaker(Honoraria); Bioderma – Speaker/Faculty Education(Honoraria); Celgene Corporation – Investigator(Grants/Research Funding); Cutera, Inc. – Advisory Board(Honoraria); Galderma Research & Development, LLC – Advisory Board(Honoraria); GlaxoSmithKline – Speaker/Faculty Education(Honoraria); Hyphens Pharma – Speaker/Faculty Education(Honoraria); Incyte Corporation – Investigator(Fees), Speaker/Faculty Education(Honoraria); ISDIN – Advisory Board(Honoraria), Speaker(Honoraria); Janssen-Cilag – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); Journal of the European Academy of Dermatology and Venereology – Other(No Compensation Received); L'Oréal Research and Innovation – Speaker/Faculty Education(Honoraria); La Roche-Posay Laboratorie Pharmaceutique – Speaker/Faculty Education(Honoraria); Leo Pharma Inc. – Speaker/Faculty Education(Honoraria); Lilly ICOS LLC – Speaker/Faculty Education(Honoraria); Mesoestetic USA Laboratories – Advisory Board(Honoraria); MSD – Advisory Board(Honoraria); Novartis – Advisory Board(Honoraria), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Speaker/Faculty Education(Honoraria); Symrise – Advisory Board(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); Vichy Laboratoires – Advisory Board(Honoraria), Speaker(Honoraria); VYNE Therapeutics – Advisory Board(Honoraria);
Melissa Piliang, MD, FAAD
AbbVie – Advisory Board(Honoraria), Investigator(No Compensation Received); Eli Lilly and Company – Investigator(No Compensation Received), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(No Compensation Received), Speaker(Honoraria); Procter & Gamble Company – Consultant(Honoraria); Sanofi – Investigator(No Compensation Received);
Bianca Maria Piraccini, MD, IFAAD
Difa Cooper – Consultant (1099 relationship)(Honoraria); Eli Lilly – Advisory Board(Fees); Giuliani Pharma – Consultant (1099 relationship)(Honoraria); L'Oréal France – Advisory Board(Fees); Pfizer Inc. – Consultant (1099 relationship)(Honoraria); Pierre Fabre Dermo Cosmetique France – Advisory Board(Fees);
Tadashi Terui
AbbVie – Other(Honoraria); Amgen Inc. – Other(Honoraria); Boehringer Ingelheim – Other(Honoraria); Bristol Myers Squibb – Other(Honoraria); Eli Lilly – Other(Honoraria); Janssen Pharmaceuticals, Inc – Other(Honoraria); Kyowa Hakko Kirin Pharma, Inc. – Other(Honoraria); Leo Pharma Inc – Other(Honoraria); Maruho Co., Ltd – Other(Grants/Research Funding); Mitsubishi Tanabe Pharma Corporation – Other(Honoraria); Novartis – Other(Honoraria); Sanofi – Other(Honoraria); Taiho Pharmaceutical Co., Ltd. – Other(Honoraria); UCB Japan – Other(Honoraria);
Hensin Tsao, MD, PhD, FAAD
Epiphany Dermatology – Advisory Board(Honoraria), Advisory Board(Stock Options); Massachusetts General Hospital – Employee(Salary); UpToDate, Inc. – Other(Honoraria);
Sandy Sharon Tsao, MD, FAAD
Beiersdorf, Inc. – Consultant (1099 relationship)(Honoraria); Epiphany Dermatology – Advisory Board(Stock);
Christina Weng, MD, FAAD
No financial relationships exist with ineligible companies.